4//SEC Filing
Love Colin 4
Accession 0001104659-21-052071
CIK 0001737953other
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 6:35 PM ET
Size
7.5 KB
Accession
0001104659-21-052071
Insider Transaction Report
Form 4
Love Colin
Chief Operating Officer10% Owner
Transactions
- Sale
Common Stock
2021-04-15$30.69/sh−27,300$837,837→ 898,509 total - Sale
Common Stock
2021-04-15$29.98/sh−2,700$80,946→ 895,809 total
Footnotes (4)
- [F1]The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 12, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.22 to $31.19. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.76 to $30.17. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F4]Following the sales reported on this Form 4, the reporting person continues to beneficially own 895,809 shares of the Issuer's common stock. The reporting person also holds options to acquire 503,578 shares of the Issuer's common stock, 274,077 of which are exercisable as of the date hereof.
Documents
Issuer
Replimune Group, Inc.
CIK 0001737953
Entity typeother
Related Parties
1- filerCIK 0001376493
Filing Metadata
- Form type
- 4
- Filed
- Apr 18, 8:00 PM ET
- Accepted
- Apr 19, 6:35 PM ET
- Size
- 7.5 KB